2010 US-HUPO Conference -- Proteomics from Bench to Clinic

描述(由申请人提供)： 我们要求为2010年3月7日至10日在科罗拉多州丹佛市举行的美国-辉宝2010年“蛋白质组学从工作台到临床”年会的运作提供部分资金支持。这次会议一直是，并将继续是美国-HuPo的一次重要的、出席人数众多的会议，该协会是美国主要的蛋白质组学研究机构，针对生物和临床问题进行研究。US-HuPo专注于将蛋白质组学应用于生物医学问题和转化医学，其范围超越了质谱学，包括蛋白质微阵列、荧光生物传感器设计以及生物标记物的发现和验证。自2005年会议开始以来，会议主席组织了一些项目，推动了快速发展的蛋白质组学领域的发展。这次会议的订阅量很大，吸引了该领域最高质量的演讲者。2010年年会将汇聚一批处于蛋白质组学前沿的杰出和多样化的科学家。研讨会上的特邀演讲将明确讨论与心血管疾病、癌症、糖尿病和肥胖症、传染病、呼吸道疾病和神经疾病相关的应用。选定的主题将向与会者介绍技术和方法开发的最新进展，说明对尖端生物学和临床问题的成功应用，并突出该领域未来的新方向。将就关键主题举行小组讨论，以鼓励演讲者和与会者之间进行强有力的对话，讨论蛋白质组学未来的关键目标，概述预期的障碍，并集思广益地解决方案。将有充足的时间用于社交场所，让与会者相互见面，建立新的联系和合作。受邀发言者中至少有31%是妇女或少数群体成员，23%是新的调查员(助理/协理级别)。预计将有300-400人参加，其中包括70-100名学生/博士后。报名不受限制，所有感兴趣的人都可以参加。将特别努力招募少数族裔参与者和来自行业的参与者。参与者将在每天下午展示关于新发现的海报。重要的是，这次会议为年轻研究人员提供了一个论坛，让他们看到基础科学研究与应用科学方法设计有效的人类疾病干预措施之间的联系。为强调这一目标，将在主要会议期间选择23个补充会议主题的海报陈述作为简短的口头陈述。与公共健康相关：需要资金支持美国人类蛋白质组组织(US-HUPO)2010年年会，该组织的使命是促进科学和教育活动，鼓励使用新技术来分析人体组织和体液中的蛋白质以及模型生物，最终目标是开发急需的早期发现人类疾病的方法和治疗当代影响全球数百万人的健康问题的新疗法。

DESCRIPTION (provided by applicant): We request partial funding support for operation of the 2010 Annual Meeting of US-HUPO on "Proteomics from Bench to Clinic", to be held March 7-10, 2010 in Denver, Colorado. This meeting has been and continues to be a vital, well-attended conference of US-HUPO, the premier U.S. society for research in proteomics as directed towards biological and clinical questions. US-HUPO has the unique niche of focusing on applications of proteomics towards biomedical problems and translational medicine, and its scope goes beyond mass spectrometry to include protein microarrays, fluorescence biosensor design, and biomarker discovery and validation. Since the conference began in 2005, its chairs have organized programs that have driven the evolution of the rapidly moving field of proteomics. The conference is heavily subscribed and attracts the highest quality speakers in this field. The 2010 Annual Meeting will bring together an outstanding and diverse group of scientists at the forefront of proteomics. Invited talks in the symposium will explicitly discuss applications relevant to cardiovascular disease, cancer, diabetes and obesity, infectious diseases, airways diseases, and neurological diseases. The topics chosen will bring participants up to date on the latest advances in technology and methods development, illustrate successful applications to cutting-edge biological and clinical problems, and highlight new directions for the future of this field. Panel discussions will be held on key topics in order to encourage a robust dialogue between speakers and meeting participants to discuss critical goals for the future in proteomics, outline anticipated obstacles, and brainstorm solutions. Ample time will be devoted to social venues for attendees to meet each other and establish new contacts and collaborations. At least 31% of the invited speakers are either women or else members of minority groups and 23% are new investigators (Assistant/Associate level). Attendance is expected at 300-400 participants, including 70-100 students/postdocs. Registration is not restricted, and all interested persons may attend. A special effort will be made to recruit minority participants and participants from industry. Participants will present posters on new findings each afternoon. Importantly, the conference provides a forum for young investigators to see the connection between fundamental scientific inquiry and the application of scientific methods to the design of efficacious interventions for human disease. To emphasize this goal, 23 poster presentations that complement the themes of the meeting will be selected for short oral presentations during the main sessions. PUBLIC HEALTH RELEVANCE: Funding is requested to support the 2010 Annual Meeting of the U.S. Human Proteome Organization (US-HUPO), whose mission is to promote scientific and educational activities to encourage the use of new technologies for analyzing proteins in human tissues and fluids, and model organisms, with the ultimate goal of developing critically needed methods for early detection of human diseases and new therapies for treating contemporary health problems that affect millions of people worldwide.